Glyburide and Peg-intron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glyburide (glyburide) and Peg-intron (peginterferon alfa-2b). Common drug interactions include abdominal pain among females and haemoglobin decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Glyburide and Peg-intron. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Glyburide?

Glyburide has active ingredients of glyburide. It is often used in diabetes. eHealthMe is studying from 38,448 Glyburide users. Check the latest studies of Glyburide.

What is Peg-intron?

Peg-intron has active ingredients of peginterferon alfa-2b. eHealthMe is studying from 11,142 Peg-intron users. Check the latest studies of Peg-intron.



On Jul, 14, 2026

48 people who take Glyburide and Peg-intron together, and have interactions are studied.

Glyburide and Peg-intron drug interactions.

What are the common drug interactions of Glyburide and Peg-Intron, by gender? *:

female:

  1. Abdominal pain
  2. Cardiac failure congestive
  3. Cerebral haemorrhage (bleeding within the brain)
  4. Clostridial infection (infectious conditions by clostridium bacteria)
  5. Constipation
  6. Death
  7. Death unexplained
  8. Diabetes mellitus inadequate control
  9. Diarrhoea
  10. Electrolyte imbalance

male:

  1. Haemoglobin decreased
  2. White blood cell count decreased
  3. Aspartate aminotransferase increased
  4. Blood potassium decreased
  5. Cellulitis (infection under the skin)
  6. Cerebellar infarction (impaired blood circulation to cerebellum)
  7. Dizziness
  8. Dyspnoea (difficult or laboured respiration)
  9. Gait disturbance
  10. General physical condition

What are the common drug interactions of Glyburide and Peg-Intron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Gas gangrene (bacterial infection that produces gas within tissues)
  2. Death unexplained
  3. Dizziness
  4. Erectile dysfunction
  5. Facial palsy (paralysis of face nerve)
  6. Fasciitis (infection of muscle surrounding tissue)
  7. Haematocrit decreased
  8. Haemoglobin decreased
  9. Influenza like illness
  10. Laceration (tearing of soft body tissue)

50-59:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Multi-organ failure (multisystem organ failure)
  3. Orchitis noninfective (non infectious inflammation of the testes)
  4. Panophthalmitis (inflammation of all the eye structures or tissues)
  5. Perinephric abscess
  6. Photophobia (extreme sensitivity to light)
  7. Platelet count decreased
  8. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  9. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  10. Postoperative infection

60+:

  1. Blood pressure increased
  2. Anaemia (lack of blood)
  3. Constipation
  4. Coronary artery embolism (blockage of artery of heart)
  5. Death
  6. Dizziness
  7. Dysarthria (speech disorder)
  8. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  9. Encephalopathy (functioning of the brain is affected by some agent or condition)
  10. Fall

What are the existing conditions these people have? *

  1. Hepatitis C: 43 people, 89.58%
  2. Nerve Compression: 5 people, 10.42%
  3. Glaucoma (increased fluid pressure in the eye with vision loss): 5 people, 10.42%

* Approximation only. Some reports may have incomplete information.

Do you take Glyburide and Peg-intron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Glyburide and Peg-intron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Glyburide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Peg-intron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glyburide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Peg-intron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on glyburide and peginterferon alfa-2b (the active ingredients of Glyburide and Peg-intron, respectively), and Glyburide and Peg-intron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: